Submit manuscript

Efficacy of Balloon Angioplasty to Correct Intragraft Stenosis during the Surgical Revision of Thrombosed Dialysis Graft: A Prospective Randomized Controlled Trial

Supachai Chanvitan MD*, Suthas Horsirimanont MD*, Sopon Jirasiritum MD*, Surasak Leela-Udomlipi MD*, Piyanut Pootracool MD*, Nutsiri Kittitirapong MD*, Sakda Arj-Ong Vallibhakara MD, PhD**, Wiwat Tirapanich MD*

Affiliation : * Division of Vascular Surgery and Transplantation, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. ** Section for Clinical Epidemiology and Biostatistics, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Background : Intragraft stenosis is luminal narrowing of prosthetic AV graft for hemodialysis remote from the vascular anasto- moses and is related to the development of peri-graft scar and fibroblastic in growth through needle puncture tracts at the access cannulation sites. If intragraft stenosis is not detected and correct during surgical revision of acutely thromboses AV graft it will lead to early rethrombosis
Objective : To compare between surgical revision with adjunctive balloon angioplasty on intragraft stenosis (intervention group) and surgical revision alone (control group) in post-intervention primary patency rate, the efficacy of balloon angioplasty on intragraft stenosis and incidence of intragraft stenosis in thrombosed dialysis graft. Material and Method: Between March 2016 and January 2017, All thrombosed dialysis graft patients at Ramathibodi Hospital were analyzed (n = 104). Grafts created less than 3 months or more than 2 years, a graft with infection, contrast allergy, and surgical revision more than twice were excluded. Forty-two patients were enrolled and randomly assigned to control and intervention group. All patients underwent surgical revision and intraoperative fistulography. Adjunctive balloon angioplasty was performed in the intervention group if intragraft stenosis with 50% or greater luminal narrowing was detected. Patency rates were estimated by Kaplan-Meier survival analysis.
Results : The two groups exhibited similar demographic features and comorbidities (p>0.05). A median follow-up time is 124 days (95% CI 126 to 291). No significant difference in overall post-intervention primary patency rate between the two groups (p = 0.973), at 3-month follow-up of control group [75% (95% CI 0.57 to 0.86)] and intervention group [78% (95% CI 0.61 to 0.88)]. And at 6-month follow-up of control group [62% (95% CI 0.43 to 0.76)] and intervention group [58% (95% CI 0.38 to 0.73)]. In subgroup analysis of patients who had intragraft stenosis, the post-intervention primary patency rate of the intervention group was higher than in the control group (p = 0.009). At 3-month follow-up of control group [62% (95% CI 0.23 to 0.86)] and intervention group [87% (95% CI 0.38 to 0.98)]. And at 6-month follow-up of the control group [0%] and the intervention group [31% (95% CI 0.04 to 0.64)]. Anatomic success rate after balloon angioplasty was 100%. The incidence of intragraft stenosis was 28.5% (12/42). Conclusions: Incidence of intragraft stenosis was 28.5% and could be effectively corrected by balloon angioplasty, therefore resulting in prolonged vascular access function.

Keywords : Thrombosed grafts, Prosthetic arteriovenous graft, Thrombosed prosthetic hemodialysis grafts, Balloon angioplasty, Intragraft stenosis


All Articles Download


INFORMATION

Contact info

JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND
4th Floor, Royal Golden Jubilee Building,
2 Soi Soonvijai, New Petchburi road,
Bangkok 10310, Thailand.
Phone: 0-2716-6102, 0-2716-6962
Fax: 0-2314-6305
Email: editor@jmatonline.com

JMed Assoc Thai
MEDICAL ASSOCIATION OF THAILAND
ISSN: 0125-2208 (Print),
ISSN: 2408-1981 (Online)
The content of this site is intended for health professionals.

Submissions

» Online Submissions » Author Guidelines » Copyright Notice » Privacy Statement

Other

» Journal Sponsorship » Site Map » About this Publishing System

© MEDICAL ASSOCIATION OF THAILAND. All Rights Reserved. The content of this site is intended for health professionals.